Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

June 2023; Volume 43,Issue 6

Review

  • Open Access
    Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor
    SANT P. CHAWLA, OLGA OLEVSKY, GEETA IYENGAR, DON A. BRIGHAM, NADEZHDA OMELCHENKO, SONU THOMAS, KUSHAL SURYAMOHAN, LELAND FOSHAG, FREDERICK L. HALL and ERLINDA M. GORDON
    Anticancer Research June 2023, 43 (6) 2383-2391; DOI: https://doi.org/10.21873/anticanres.16406

Experimental Studies

  • Open Access
    Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells
    KONAN J.W. KANGA, LAMBERT H.B. KANGA, PATRICIA MENDONCA, KARAM F.A. SOLIMAN, DOMINIQUE T. FERGUSON, SARAH L. REED and SELINA DARLING-REED
    Anticancer Research June 2023, 43 (6) 2393-2405; DOI: https://doi.org/10.21873/anticanres.16407
  • Open Access
    Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
    ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN
    Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
  • You have access
    Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy
    MASAFUMI IGUCHI, SHIGEKI YAGYU, KOSUKE KAMBE, MAYUMI HIGASHI, SHIGEHISA FUMINO, TSUNAO KISHIDA, TOMOKO IEHARA, OSAM MAZDA and TATSURO TAJIRI
    Anticancer Research June 2023, 43 (6) 2417-2424; DOI: https://doi.org/10.21873/anticanres.16409
  • Open Access
    Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody
    YURINA SAITO, TSUYOSHI TAKAHASHI, KOSUKE HIRAMATSU, SATOSHI SERADA, MINORU FUJIMOTO, TOMOHARU OHKAWARA, TAKAHITO SUGASE, TAKAHIKO NISHIGAKI, KOJI TANAKA, YASUHIRO MIYAZAKI, TOMOKI MAKINO, YUKINORI KUROKAWA, KIYOKAZU NAKAJIMA, MAKOTO YAMASAKI, KEN J. ISHII, HIDETOSHI EGUCHI, YUICHIRO DOKI and TETSUJI NAKA
    Anticancer Research June 2023, 43 (6) 2425-2432; DOI: https://doi.org/10.21873/anticanres.16410
  • Open Access
    Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells
    TAKAFUMI SHIMADA, RENATO NAITO, REN TORIUMI, RYUNOSUKE NAKAGAWA, SHUHEI AOYAMA, TAIKI KAMIJIMA, HIROSHI KANO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KOUJI IZUMI, YOSHIFUMI KADONO, HIROKI NAKATA, YOHEI SAITO, KYOKO NAKAGAWA-GOTO and ATSUSHI MIZOKAMI
    Anticancer Research June 2023, 43 (6) 2433-2444; DOI: https://doi.org/10.21873/anticanres.16411
  • You have access
    Differential Effects of Anti-PD-1/PD-L1 Checkpoint Inhibitors on Adhesion Molecules and Cytokine Secretion by THP-1 Monocytes
    EVA PROBST, KLAAS F. FRANZEN, CHRISTIAN IDEL, KIRSTIN PLÖTZE-MARTIN, JONAS FLECKNER, DIRK RADES, SABINE BOHNET, KARL-LUDWIG BRUCHHAGE and RALPH PRIES
    Anticancer Research June 2023, 43 (6) 2445-2454; DOI: https://doi.org/10.21873/anticanres.16412
  • You have access
    Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization
    HARUKA UMEYAMA, ZENPEI SHIGEMI, YUSUKE BABA, NAOKO HARA, TADASHI WATANABE and MASAHIRO FUJIMURO
    Anticancer Research June 2023, 43 (6) 2455-2465; DOI: https://doi.org/10.21873/anticanres.16413
  • Open Access
    Involvement of Mitochondrial Damage and Oxidative Stress in Apoptosis Induced by Betulin Plus Arsenic Trioxide in Neuroblastoma Cells
    KAI-YUAN CHEN, WEI-LIN HSU, SHIH-WEI HSU, CHAO-HSUAN CHEN, KUN-TING HONG, CHIA-WEN TSAI, WEN-SHIN CHANG, CHAO-CHUN CHEN, JEN-SHENG PEI, HSU-TUNG LEE and DA-TIAN BAU
    Anticancer Research June 2023, 43 (6) 2467-2476; DOI: https://doi.org/10.21873/anticanres.16414
  • Open Access
    Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells
    DAISUKE TATSUDA, JUNJIRO YOSHIDA, TOMOKAZU OHISHI and MANABU KAWADA
    Anticancer Research June 2023, 43 (6) 2477-2489; DOI: https://doi.org/10.21873/anticanres.16415
  • You have access
    CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal Metastasis After Surgery
    ANDREAS MICHAEL SIHOMBING, SATOSHI MURATA, MIYUKI SHIMOJI, TORU MIYAKE, KATSUSHI TAKEBAYASHI, HIROKAZU KODAMA, AYA TOKUDA, MASATSUGU KOJIMA, TOMOYUKI UEKI, NAOMI KITAMURA, MINA KITAMURA, EIJI MEKATA and MASAJI TANI
    Anticancer Research June 2023, 43 (6) 2491-2500; DOI: https://doi.org/10.21873/anticanres.16416
  • You have access
    Acquired AKT-inhibitor Resistance Is Mediated by ATP-binding Cassette Transporters in Endometrial Carcinoma
    SHOJI TAKAGI, TAKAFUMI ONISHI, TSUYOSHI TAKASHIMA, KAZUKI SHIBAHARA and MICHIHIRO MORI
    Anticancer Research June 2023, 43 (6) 2501-2507; DOI: https://doi.org/10.21873/anticanres.16417
  • You have access
    Selective Inhibition of L-type Amino Acid Transporter 1 Suppresses Cell Proliferation in Ovarian Clear Cell Carcinoma
    MASAKI SEKINE, IEMASA KOH, KOSUKE NAKAMOTO, SUGURU NOSAKA, KATSUYUKI TOMONO, JUN SUGIMOTO and YOSHIKI KUDO
    Anticancer Research June 2023, 43 (6) 2509-2517; DOI: https://doi.org/10.21873/anticanres.16418
  • You have access
    Casein Kinase 2α Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression
    CHUL WON YUN, JUN HEE LEE and SANG HUN LEE
    Anticancer Research June 2023, 43 (6) 2519-2525; DOI: https://doi.org/10.21873/anticanres.16419
  • You have access
    Overexpression of c-MYC Promoter Binding Protein-1 Enhances Proliferation and Glucose Metabolism of Melanoma Cells Lines
    MIRIAM HIPPNER-KUNICKA, AGNIESZKA LASZKIEWICZ, JOANNA SKRZYMOWSKA, PRZEMYSLAW BIECEK, PIOTR DONIZY and ARKADIUSZ MIAZEK
    Anticancer Research June 2023, 43 (6) 2527-2538; DOI: https://doi.org/10.21873/anticanres.16420
  • You have access
    Sodium Valproate Enhances Semaphorin 3A-mediated Anti-angiogenesis and Tumor Growth Inhibition in Human Osteosarcoma Cells
    TATSUO SAWAI, KOJI YAMANEGI, HIROSHI NISHIURA, HIROYUKI FUTANI and TOSHIYA TACHIBANA
    Anticancer Research June 2023, 43 (6) 2539-2550; DOI: https://doi.org/10.21873/anticanres.16421
  • You have access
    Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
    YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA and TETSUO NAKAJIMA
    Anticancer Research June 2023, 43 (6) 2551-2559; DOI: https://doi.org/10.21873/anticanres.16422
  • You have access
    The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells
    ARIUNBOLD NATSAGDORJ, KOUJI IZUMI, KAORU HIRATSUKA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, HIROKI NAKATA and ATSUSHI MIZOKAMI
    Anticancer Research June 2023, 43 (6) 2561-2569; DOI: https://doi.org/10.21873/anticanres.16423
  • You have access
    P4HA1 Promotes Cell Migration and Colonization in Hypopharyngeal Squamous Cell Carcinoma
    KANAME SATO, DAISUKE SANO, HIDEAKI TAKAHASHI, TATSU KUWAHARA, YOSHIHIRO AIZAWA, JUN AOYAMA, YUSUKE NOJIMA, TAKASHI HATANO, YASUHIRO ARAI, GOSHI NISHIMURA, HIROMITSU HATAKEYAMA and NOBUHIKO ORIDATE
    Anticancer Research June 2023, 43 (6) 2571-2582; DOI: https://doi.org/10.21873/anticanres.16424
  • You have access
    Serum Starvation Induces Matrix Metalloproteinase 9 Expression in Nasopharyngeal Carcinoma Cells Through the ERK-AP1 Pathway In Vitro
    YEN-TING WU, CHUNG-CHI HSU, BU-MIIN HUANG, YUN-CHING CHANG, CHENG-HAN LIN and YU-YAN LAN
    Anticancer Research June 2023, 43 (6) 2583-2591; DOI: https://doi.org/10.21873/anticanres.16425
  • You have access
    Metabolic Changes in Blood-derived Extracellular Vesicles of Malnourished Breast Cancer Patients
    JUDITH BUENTZEL, MATTHIAS SCHULZ, LENA APERDANNIER, ANNALEN BLECKMANN and CLAUDIA BINDER
    Anticancer Research June 2023, 43 (6) 2593-2599; DOI: https://doi.org/10.21873/anticanres.16426
  • You have access
    The Expression and Role of NADPH Oxidase 2 in Colon Cancer
    KOICHI TAKIGUCHI, HIROKI SHIMIZU, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, NAOHIRO HOSOMURA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, KUNIO MOCHIZUKI, TETSUO KONDO and DAISUKE ICHIKAWA
    Anticancer Research June 2023, 43 (6) 2601-2608; DOI: https://doi.org/10.21873/anticanres.16427
  • You have access
    The Suppressive Effect of Rebastinib on Triple-negative Breast Cancer Tumors Involves Multiple Mechanisms of Action
    KUNXIAN FENG, CHENGFANG JIAN, HAIHUA XIAO, HUANGYU JIANG, JINPING YANG, MENGLI YANG, ANDRE SUN, WENMING SONG, ALEXANDER V. CHESTKOV, NATALYA I. VASILEVICH and LICHUN SUN
    Anticancer Research June 2023, 43 (6) 2609-2624; DOI: https://doi.org/10.21873/anticanres.16428
  • You have access
    11-epi-Sinulariolide Acetate-induced Apoptosis in Oral Cancer Cells Is Regulated by FOXO Through Inhibition of PI3K/AKT Pathway
    TING-SHOU CHANG, JEN-JIE LIN, KAI-CHUN CHENG, JUI-HSIN SU, YUN-YING SHE and YU-JEN WU
    Anticancer Research June 2023, 43 (6) 2625-2634; DOI: https://doi.org/10.21873/anticanres.16429
  • You have access
    TIG1 Inhibits the mTOR Signaling Pathway in Malignant Melanoma Through the VAC14 Protein
    CHUN-HUA WANG, LU-KAI WANG, CHANG-CHIEH WU, MAO-LIANG CHEN, CHAN-YEN KUO, RONG-YAUN SHYU and FU-MING TSAI
    Anticancer Research June 2023, 43 (6) 2635-2643; DOI: https://doi.org/10.21873/anticanres.16430

Clinical Studies

  • Open Access
    Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
    MINNA KANKURI-TAMMILEHTO, LAURA PERASTO, SEPPO PYRHONEN and EEVA SALMINEN
    Anticancer Research June 2023, 43 (6) 2645-2657; DOI: https://doi.org/10.21873/anticanres.16431
  • Open Access
    Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis
    PIETRO FAMILIARI, PIERFRANCESCO LAPOLLA, VERONICA PICOTTI, MAURO PALMIERI, ALESSANDRO PESCE, GIULIA CAROSI, MICHELA RELUCENTI, STEFANIA NOTTOLA, FRANCESCA GIANNO, SIMONE MINASI, MANILA ANTONELLI, ALESSANDRO FRATI, ANTONIO SANTORO, GIANCARLO D’ANDREA, PLACIDO BRUZZANITI and BIAGIA LA PIRA
    Anticancer Research June 2023, 43 (6) 2659-2670; DOI: https://doi.org/10.21873/anticanres.16432
  • Open Access
    Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo- or Adjuvant Chemotherapy: A Randomised Multicentre Phase II Study. (EudraCT: 2015–000658-39)
    DELMY OLIVA, BENGT-ÅKE ANDERSSON, LEVAR SHAMOUN, NONGNIT LEWIN, MATS P. NILSSON, ELSY-BRITT SCHILDT, LISA FUST, ULRIKA ÅSENLUND, GUNILLA SELLERSTAM, ELLINOR ELINDER, LENA SHARP and FREDDI LEWIN
    Anticancer Research June 2023, 43 (6) 2671-2681; DOI: https://doi.org/10.21873/anticanres.16433
  • Open Access
    KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer
    YORIHIKO TAKASE, YOSHIKI NAITO, AKIHIKO KAWAHARA, YOSHINOBU OKABE, EIJI SADASHIMA, HIDEYUKI ABE and JUN AKIBA
    Anticancer Research June 2023, 43 (6) 2683-2690; DOI: https://doi.org/10.21873/anticanres.16434
  • Open Access
    Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery
    YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH
    Anticancer Research June 2023, 43 (6) 2691-2695; DOI: https://doi.org/10.21873/anticanres.16435
  • You have access
    Clinical Significance of Pre-treatment Circumferential Tumor Location in Patients With cStage IB-III Esophageal Squamous Cell Cancer
    SHINSUKE NAGASAWA, TAKASHI OSHIMA, KENTARO HARA, MASATO NAKAZONO, YUTA KUMAZU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO, TOMOYUKI YOKOSE and HEIKE I. GRABSCH
    Anticancer Research June 2023, 43 (6) 2697-2705; DOI: https://doi.org/10.21873/anticanres.16436
  • Open Access
    Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors
    JINAH CHU, YUMIN CHUNG, SEOUNG WAN CHAE, YOUNG-JUN CHOI, HYUN-SOO KIM and SUNG-IM DO
    Anticancer Research June 2023, 43 (6) 2707-2715; DOI: https://doi.org/10.21873/anticanres.16437
  • You have access
    Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study
    TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, KUNIHIKO TOKASHIKI, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, KOKI MIURA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA
    Anticancer Research June 2023, 43 (6) 2717-2724; DOI: https://doi.org/10.21873/anticanres.16438
  • Open Access
    Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy
    OKSANA ZEMSKOVA, NATHAN Y. YU, PETER TRILLENBERG, MATTEO M. BONSANTO, JAN LEPPERT and DIRK RADES
    Anticancer Research June 2023, 43 (6) 2725-2732; DOI: https://doi.org/10.21873/anticanres.16439
  • You have access
    Dose-dependent Effects of Unintended Splenic Irradiation After Neoadjuvant Radiochemotherapy for Esophageal Cancer
    EREN CELIK, CHRISTIAN BAUES, MAIKE TROMMER, JIAQI FAN, LUKAS NADJIRI, JOHANNES ROSENBROCK and PHILIPP LINDE
    Anticancer Research June 2023, 43 (6) 2733-2739; DOI: https://doi.org/10.21873/anticanres.16440
  • You have access
    Robotic Retroperitoneal Versus Transperitoneal Partial Nephrectomy: Outcomes and Learning Curve
    NICOLAS FISCHER, TOBIAS KOWALKE, MANUELA A. HOFFMANN and DANIEL PORRES
    Anticancer Research June 2023, 43 (6) 2741-2747; DOI: https://doi.org/10.21873/anticanres.16441
  • You have access
    Impact of Minimally Invasive Intrathoracic Hand-sewn Esophago-gastric Anastomosis in Esophagectomy for Cancer
    ALEXANDROS CHARALABOPOULOS, SPYRIDON DAVAKIS, PANAGIOTIS SAKARELLOS, EFSTRATIA MPAILI, ELENI SARLANI, STRATIGOULA SAKELLARIOU, DIMITRIOS ZIOGAS, MARIA THEOCHARI and THEODOROS LIAKAKOS
    Anticancer Research June 2023, 43 (6) 2749-2755; DOI: https://doi.org/10.21873/anticanres.16442
  • You have access
    Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases
    LEONIE JOHANNWERNER, ELISA M. WERNER, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES
    Anticancer Research June 2023, 43 (6) 2757-2762; DOI: https://doi.org/10.21873/anticanres.16443
  • Open Access
    Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases
    DIRK RADES, LEONIE JOHANNWERNER, NATHAN Y. YU and JAN GLIEMROTH
    Anticancer Research June 2023, 43 (6) 2763-2770; DOI: https://doi.org/10.21873/anticanres.16444
  • Open Access
    Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation
    KENSUKE KANAOKA, AKIHIRO TAMIYA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, MAIKO TAKEDA, YOSHINOBU MATSUDA, KYOICHI OKISHIO and SHIGEKI SHIMIZU
    Anticancer Research June 2023, 43 (6) 2771-2776; DOI: https://doi.org/10.21873/anticanres.16445
  • Open Access
    Clinical Outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors
    YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH
    Anticancer Research June 2023, 43 (6) 2777-2781; DOI: https://doi.org/10.21873/anticanres.16446
  • You have access
    Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
    MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI and YASUTO NAOI
    Anticancer Research June 2023, 43 (6) 2783-2789; DOI: https://doi.org/10.21873/anticanres.16447
  • You have access
    Toxic Effects of Volume-modulated Arc Therapy for Esophageal Squamous Cell Cancer: Preliminary Clinical Results
    DAISUKE SHIGENAGA, OGINO ICHIRO, SHIGENOBU WATANABE and MASAHARU HATA
    Anticancer Research June 2023, 43 (6) 2791-2798; DOI: https://doi.org/10.21873/anticanres.16448
  • You have access
    Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients
    HELENA LINARDOU, SOFIA LAMPAKI, GEORGIA-ANGELIKI KOLIOU, ATHANASSIOS VOZIKIS, ANASTASIOS BOUTIS, ADAMANTIA NIKOLAIDI, IOANNIS KONTOGIORGOS, PAVLOS PAPAKOTOULAS, ATHINA CHRISTOPOULOU, DIONYSIOS SPYRATOS, DIMITRIOS BAFALOUKOS, AMANDA PSYRRI, ANASTASIOS GRIVAS, ANNA KOUMARIANOU, KARYOFYLLIS TSIAKITZIS, DAVIDE MAURI, GEORGIOS RIGAKOS, GERASIMOS ARAVANTINOS, PANAGIOTIS PAPANTONIOU, GEORGIOS OIKONOMOPOULOS, ELENA FOUNTZILAS, MARGARITA-IOANNA KOUFAKI, MARIA KAPARELOU, ELIAS LIOLIS, GIANNIS MOUNTZIOS, PARIS KOSMIDIS, GEORGE FOUNTZILAS and EPAMINONDAS SAMANTAS
    Anticancer Research June 2023, 43 (6) 2799-2812; DOI: https://doi.org/10.21873/anticanres.16449
  • You have access
    Lymph Node Metastasis in Extraperitoneal Rectal Cancer After Neoadjuvant Therapy: An Unsolved Problem?
    ALICE LA FRANCA, EDOARDO MARIA MUTTILLO, ISABELLA MADAFFARI, FANNY MASSIMI, GIUSEPPE LONGO, ALICE CECCACCI, ILARIA ANGELICONE, FLAVIA DE GIACOMO, ISABELLA SPERDUTI, GENOVEFFA BALDUCCI, MATTIA FALCHETTO OSTI and PAOLO MERCANTINI
    Anticancer Research June 2023, 43 (6) 2813-2820; DOI: https://doi.org/10.21873/anticanres.16450
  • You have access
    Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients
    DANIELA SAMBATARO, MARIA ROSARIA POLITI, ANGELA MESSINA, LINDA SCARPELLO, SEBASTIANO MESSINA, ROSSELLA GUGGINO, CARLO CARNAGHI, RICCARDO CACCIALANZA and VITTORIO GEBBIA
    Anticancer Research June 2023, 43 (6) 2821-2829; DOI: https://doi.org/10.21873/anticanres.16451
  • You have access
    Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer
    KEI HAYASHI, MITSUHIRO FURUTA, KYOKO FURUSAWA, TOMOMI HAMAGUCHI, MAMORU WATANABE, YASUHIRO INOKUCHI, SHIZUNE ONUMA, ITARU HASHIMOTO, HIDEAKI SUEMATSU, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, AKIFUMI NOTSU, TAKASHI OGATA, TAKASHI OSHIMA, NOZOMU MACHIDA, JUNJI FURUSE and SHIN MAEDA
    Anticancer Research June 2023, 43 (6) 2831-2840; DOI: https://doi.org/10.21873/anticanres.16452
  • You have access
    Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
    KOHEI KASAHARA, CHIKARA KUNISAKI, SHO SATO, HIROKI KONDO, MASAZUMI TAKAHASHI, YUKO TAMURA, NOBUHIRO TSUCHIYA, YUSAKU TANAKA, KEI SATO, JUN KIMURA, TAKASHI KOSAKA, HIDETAKA ONO, HIROCHIKA MAKINO, HIROTOSHI AKIYAMA and ITARU ENDO
    Anticancer Research June 2023, 43 (6) 2841-2850; DOI: https://doi.org/10.21873/anticanres.16453
  • You have access
    Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy
    EIKO ITO, ICHIRO OGINO, MADOKA SUGIURA, SHIGENOBU WATANABE, YOSHIBUMI TAYAMA, SHOKO TAKANO and MASAHARU HATA
    Anticancer Research June 2023, 43 (6) 2851-2857; DOI: https://doi.org/10.21873/anticanres.16454
  • You have access
    Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy
    KENTA KONISHI, MIKA KAMIYA, KEIICHI OHIRA, MASANORI HIRATA, KOHEI WAKABAYASHI, TSUTOMU IKENOHIRA, TAKASHI KOSUGI, TAKASUKE USHIO, ATSUSHI IMAI, DAIKI MOCHIZUKI, YUKI YAMAGUCHI, YUKICHI TANAHASHI, KIYOSHI MISAWA, SATOSHI GOSHIMA and KATSUMASA NAKAMURA
    Anticancer Research June 2023, 43 (6) 2859-2864; DOI: https://doi.org/10.21873/anticanres.16455
  • You have access
    Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer
    KEISUKE KOMORI, KAZUKI KANO, SHUJI ANDO, HAYATO WATANABE, KOSUKE TAKAHASHI, YUKIO MAEZAWA, HIROHITO FUJIKAWA, SHO SAWAZAKI, MASAKATSU NUMATA, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research June 2023, 43 (6) 2865-2871; DOI: https://doi.org/10.21873/anticanres.16456
  • You have access
    Successful Treatment of Refractory Enterocutaneous Fistula After Esophagectomy Using Soft Coagulation by an Endoscopic and Percutaneous Approach: A Case Report
    SHUHEI ITO, KIPPEI OHGAKI, TETSURO KAWAZOE, HUANLIN WANG, YASUHARU OKAMOTO, EISUKE ADACHI and YOICHI IKEDA
    Anticancer Research June 2023, 43 (6) 2873-2877; DOI: https://doi.org/10.21873/anticanres.16457
  • You have access
    CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy
    HIDEKO AKAGI, YUSAKU TANAKA, KOHEI WADA, MIANAMI TAKAHASHI, KOUDAI YOSHIDA and HIDEHARU DOMOTO
    Anticancer Research June 2023, 43 (6) 2879-2884; DOI: https://doi.org/10.21873/anticanres.16458
  • Open Access
    Book Reviews
    Anticancer Research June 2023, 43 (6) 2885-2888; DOI: https://doi.org/10.21873/anticanres.16459
Back to top
PreviousNext

In this issue

Anticancer Research: 43 (6)
Anticancer Research
Vol. 43, Issue 6
June 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor
  • Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
  • Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody
  • Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells
  • Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
Sign up for alerts

Jump to

  • Review
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire